Why the study?
Does peak CK-MB predict infarct size, LVEF, and mortality better than other clinical and angiographic characteristics in STEMI patients?
Does peak CK-MB predict infarct size, LVEF, and mortality better than other clinical and angiographic characteristics in STEMI patients?
Answers are grounded in this paper and cite their sources.
Peak CK-MB during hospitalization remains a strong, easily obtainable predictor of infarct size, LVEF, and short-term mortality in STEMI patients, outperforming other clinical characteristics.
BACKGROUND: Complex multimarker approaches to predict outcome after ST-elevation myocardial infarction (STEMI) have only considered a single baseline sample, while neglecting easily obtainable peak creatine kinase and creatine kinase-MB (CK-MB) values during hospitalization. METHODS: We studied 476 patients undergoing primary percutaneous coronary intervention for STEMI and cardiac magnetic resonance imaging (CMRI) at 4-6 months after STEMI. We determined the association with cardiac biomarkers (peak CK-MB, peak troponin T, N-terminal pro-brain natriuretic peptide), clinical and angiographic characteristics with infarct size, and LVEF, followed by association with mortality in 1120 STEMI patients. The additional value of clinical and angiographic characteristics was limited. The optimal peak CK-MB cutpoints, for differentiation among small (<10% of the left ventricle), moderate (≥10%-<30%), and large infarct size (≥30%), were 210 U/L and 380 U/L, respectively. These cutpoints were associated with 90-day mortality; the hazard ratio for moderate infarct was 2.99 (95% confidence interval [CI]: 1.51-5.93, P=0.002) and for large infarct 6.53 (95% CI: 3.63-11.76, P<0.001). CONCLUSIONS: Classical peak CK-MB measured during hospitalization for STEMI was superior to other clinical and angiographic characteristics in predicting CMRI-defined infarct size and LVEF, and should be included and validated in future multimarker studies. Peak CK-MB cutpoints differentiated among infarct size categories and were associated with increased 90-day mortality risk.
No takes yet. Share an insight, caveat, or question.
Hartman et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: